stockrow
Friday 6 November 2026
Export SOPH’s income statement to Excel — free account
SOPHiA GENETICS SA
SOPH Healthcare Health Information Services
SOPHiA GENETICS SA’s revenue for fiscal 2025 (year ended December 2025) was $77.3 million, up 18.6% from fiscal 2024.
- Revenue
- +24.7%
- EPS
- +21.0%
- Free cash flow
- −1.87%
- Total debt
- +1.19%
Quarter to September 2026, against a year earlier
7.09
0.47
+7.10%
Follow SOPH
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
7.88 | 4.94 | 4.34 | 4.08 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(75.60) | (55.39) | (23.29) | (38.77) | |
P/B ratio |
10.47 | 5.13 | 7.71 | 6.69 | |
Price to Tangible BV |
21.99 | 9.07 | 35.70 | 28.03 | |
EV/Sales |
7.39 | 4.27 | 4.14 | 3.81 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(16.64) | (9.26) | (8.35) | (8.20) | |
EV/FCF |
(16.17) | (8.91) | (8.04) | (8.04) | |
Quick Ratio |
2.01 | 2.38 | 1.71 | 1.69 | |
Current Ratio |
2.29 | 2.69 | 2.06 | 1.96 | |
Net Debt/EBITDA |
3.03 | 3.48 | 1.21 | 1.40 | |
Debt/Assets |
26.06% | 24.20% | 30.47% | 29.28% | |
Debt/Equity |
0.70 | 0.58 | 1.05 | 1.01 | |
Asset Turnover |
0.52 | 0.46 | 0.53 | 0.49 | |
Operating CF/Net income |
0.47 | 0.34 | 0.78 | 0.42 | |
Capex/Depreciation |
0.10 | (0.05) | (0.33) | (0.09) | |
Interest Coverage |
(11.02) | (12.38) | (10.37) | (11.07) | |
Research and Development Expense of Revenue |
34.18% | 37.46% | 43.62% | 39.33% | |
Selling, General and Administrative Expense of Revenue |
104.93% | 113.20% | 104.08% | 113.57% | |
Intangible Assets out of Total Assets |
0.19 | 0.18 | 0.23 | 0.22 | |
Share Based Compensation of Revenue |
18.77% | 19.27% | 15.28% | 17.82% | |
Graham Net Nets |
0.01 | 0.05 | (0.04) | (0.05) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(12.97%) | (19.93%) | (23.90%) | (25.12%) | |
Free Cash Flow Yield |
(5.81%) | (9.69%) | (11.87%) | (11.61%) | |
Revenue per Share |
0.28 | 0.32 | 0.30 | 0.32 | |
Operating CF per Share |
(0.11) | (0.10) | (0.21) | (0.12) | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | |
Free Cash Flow per Share |
(0.11) | (0.11) | (0.23) | (0.12) | |
Cash per Share |
1.10 | 1.46 | 0.92 | 1.04 | |
Shareholders Equity per Share |
0.80 | 1.13 | 0.64 | 0.70 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.80 | 1.13 | 0.64 | 0.70 | |
Free Cash Flow |
(9.20) | (7.84) | (16.03) | (8.36) | |
Working Capital |
70.71 | 86.21 | 49.22 | 48.55 | |
Capital Expenditures |
0.27 | (0.15) | (0.91) | (0.22) | |
Net Current Asset Value |
9.33 | 22.05 | (15.50) | (16.81) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(0.01) | 0.01 | 0.04 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
12.59 | 11.81 | 12.50 | 11.22 | |
Average Payables |
8.17 | 9.82 | 8.64 | 7.09 | |
Average Inventory |
6.92 | 6.65 | 6.07 | 6.11 | |
Average Assets |
174.09 | 187.99 | 151.86 | 159.17 | |
Average Common Equity |
64.56 | 79.91 | 65.65 | 71.82 |
Columns are period end dates · fundamentals updated 5 Nov 2026